Ferrannini E, Niemoeller E, Dex T, Servera S, et al. Fixed-ratio combination of insulin glargine plus lixisenatide (iGlarLixi) improves ss-cell function in people with type 2 diabetes. Diabetes Obes Metab 2022 Mar 7. doi: 10.1111/dom.14688.
PMID: 35257461